Singer; Jack

Patent Applications and Registrations

Patent applications and USPTO patent grants for Singer; Jack.The latest application filed is for "conjugates of biologically active proteins having a modified in vivo half-life".

Company Profile

0.12.3

Singer; Jack - Seattle WA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Conjugates of biologically active polypeptides having an increased in vivo half-life Grant 8,748,577 - Besman , et al. June 10, 2	2014-06-10
Conjugates Of Biologically Active Proteins Having A Modified In Vivo Half-life App 20120252717 - Besman; Marc ; et al.	2012-10-04
Conjugates of biologically active proteins having a modified in vivo half-life Grant 8,129,348 - Besman , et al. March 6, 2	2012-03-06
Conjugates Of Biologically Active Proteins Having A Modified In Vivo Half-life App 20090298762 - Besman; Marc ; et al.	2009-12-03
Estrogen cancer therapy App 20070167349 - Singer; Jack	2007-07-19
Enantiomerically pure hydroxylated xanthine compounds Grant 5,965,564 - Bianco , et al. October 12, 1	1999-10-12
Enatiomerically pure hydroxylated xanthine compounds Grant 5,792,772 - Bianco , et al. August 11, 1	1998-08-11
Enantiomerically pure hydroxylated xanthine compounds to treat autoimmune diabetes Grant 5,739,138 - Bianco , et al. April 14, 1	1998-04-14
Methods of using enantiomerically pure hydroxylated xanthine compounds Grant 5,652,243 - Bianco , et al. July 29, 1	1997-07-29
Enatiomerically pure hydroxylated xanthine compounds Grant 5,648,357 - Bianco , et al. July 15, 1	1997-07-15
Treatment of diseases using enantiomerically pure hydroxylated xanthine compounds Grant 5,629,315 - Bianco , et al. * May 13, 1	1997-05-13
Process for preparing enantiomerically pure xanthine derivatives Grant 5,621,102 - Bianco , et al. April 15, 1	1997-04-15
Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases Grant 5,620,984 - Bianco , et al. April 15, 1	1997-04-15
Enatiomerically pure hydroxylated xanthine compounds Grant 5,580,874 - Bianco , et al. December 3, 1	1996-12-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.